American Society for Transplantation and Cellular Therapy Series: #3—Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation

Resource type
Journal Article
Authors/contributors
Title
American Society for Transplantation and Cellular Therapy Series: #3—Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation
Abstract
The Practice Guidelines Committee of the American Society for Transplantation and Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to update its 2009 compendium-style infectious diseases guidelines for the care of hematopoietic cell transplant (HCT) recipients. A new approach was taken with the goal of better serving clinical providers by publishing each standalone topic in the infectious disease series as a concise format of frequently asked questions (FAQ), tables, and figures. Adult and pediatric infectious disease and HCT content experts developed and answered FAQs. Topics were finalized with harmonized recommendations that were made by assigning an A through E strength of recommendation paired with a level of supporting evidence graded I through III. The third topic in the series focuses on the prevention of cytomegalovirus infection and disease in HCT recipients by reviewing prophylaxis and preemptive therapy approaches; key definitions, relevant risk factors, and diagnostic monitoring considerations are also reviewed.
Publication
Transplantation and Cellular Therapy
Date
09/2021
Volume
27
Issue
9
Pages
707-719
Journal Abbr
Transplantation and Cellular Therapy
Accessed
10/23/21, 9:54 AM
ISSN
26666367
Short Title
American Society for Transplantation and Cellular Therapy Series
Language
en
Library Catalog
DOI.org (Crossref)
Citation
Hakki, M., Aitken, S. L., Danziger-Isakov, L., Michaels, M. G., Carpenter, P. A., Chemaly, R. F., Papanicolaou, G. A., Boeckh, M., & Marty, F. M. (2021). American Society for Transplantation and Cellular Therapy Series: #3—Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy, 27(9), 707–719. https://doi.org/10.1016/j.jtct.2021.05.001
GUIDELINES